Dihydroetorphine
Chemistry
- Formula
- C25H35NO4
- Molar mass
- 413.5 g/mol
- IUPAC name
- (1S,2S,6R,14R,15R,16R)-16-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol
- InChIKey
- BRTSNYPDACNMIP-FAWZKKEFSA-N
Chemistry from PubChem CID 107765.
Also known as
- 14357-76-7
- 18,19-Dihydroetorphine
- QQX8S479YV
- IDS-ND-025
- DTXSID60905082
- Tetrahydro-7alpha-(1-hydroxy-1-methylbutyl)-6,14-endo-ethanooripavine
- RefChem:133816
- DTXCID301334184
Stereoisomers
6 distinct stereoisomers are registered for this structure.
- Dihydroetorphine this area CID 107765
- (1S,2S,6R,14R,15S,16R)-16-[(2S)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol CID 11973110
- (1S,2R,6S,14R,15S,16R)-16-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol CID 23786503
- (1S,2S,6R,14R,15S,16R)-16-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol CID 58480455
- (1R,2S,6R,14R,15S,16R)-16-[(2R)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol CID 101652243
- (1S,2S,6R,14R,15R,16R)-16-[(2S)-2-hydroxypentan-2-yl]-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol CID 118067381
- 16-(2-Hydroxypentan-2-yl)-15-methoxy-5-methyl-13-oxa-5-azahexacyclo[13.2.2.12,8.01,6.02,14.012,20]icosa-8(20),9,11-trien-11-ol mixture CID 21863261
General Open discussion — anything that fits nowhere narrower. no posts yet Legal Scheduling status, pending actions, and where the law actually stands. no posts yet Dosage Dose ranges by route, and the margins between them. no posts yet Experiences First-hand reports — set, setting, and what actually happened. no posts yet Chemistry Structure, synthesis, and analytical chemistry. no posts yet Interactions Combination risks — what must not be mixed, and why. no posts yet
No posts here yet.